Abiopharma

🔍 Taylor Daniel Mark (Executive)

Company: Flutter Entertainment plc (FLUT)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 791 shares of Ordinary Shares at $97.859 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 52,467.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 7,902 shares of Nil Cost Options (Right to Buy) (Derivative)
  Date: 2026-09-01 | Code: D | Expires: 2033-03-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F3
• Sold 5,639 shares of Nil Cost Options (Right to Buy) (Derivative)
  Date: 2026-09-01 | Code: D | Expires: 2034-04-02 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F4
• Acquired 13,541 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,541.00 | transaction_form_type: 4 | Footnotes: F5, F2, F2, F6, F6

Footnotes:

• F1: Reflects shares sold to cover tax withholding liability in connection with the vesting and settlement of RSUs.
• F2: Reflects the conversion of Nil Cost Options to RSU awards subject to the same terms and conditions as the Nil Cost Options. No new grants were made in connection with these conversions.
• F3: These options vest on October 1, 2026.
• F4: These options vest on September 1, 2027.
• F5: Each RSU represents the contingent right to receive one ordinary share.
• F6: These RSUs vest as follows: (a) 7,902 vest on October 1, 2026, and (b) 5,639 vest on September 1, 2027.